Search results

Found 2,503 pages
AUTHOR: Peter Mansell

Results per page

10 20 50 100

Sort by

Relevance Date

26 Mar 2013:

Early-phase obesity focus for WCCT Global

US-based contract research organisation WCCT Global is ramping up its early-phase efforts in the field of obesity to address a “continually mounting” epidemic fuelled by unhealthy lifestyles and diets. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/early-phase_obesity_focus_for_wcct_global_1004704

19 Dec 2007:

PPD expands Phase II-IV services

US-based contract research organisation (CRO) PPD continues to expand the global footprint for its Phase II-IV clinical trial services, announcing a new appointment to drive expansion on the Indian subcontinent and opening a second office in Mumbai,

by Peter Mansell

https://www.pharmatimes.com/news/ppd_expands_phase_ii-iv_services_991650

13 Dec 2007:

Charles River sees 10-13% growth in 2008

US-based contract research organisation (CRO) Charles River Laboratories International is expecting revenue growth in the range of 10%-13% next year, including a boost of around 1% from foreign exchange. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/charles_river_sees_10-13_growth_in_2008_991606

24 Jun 2009:

PharmaLinkFHI is now Novella Clinical

US-based contract research organisation (CRO) PharmaLinkFHI has changed its name to Novella Clinical, reflecting the company’s higher global profile following its acquisition of Matrix Contract Research in the UK last September. - News -

by Peter Mansell

https://www.pharmatimes.com/news/pharmalinkfhi_is_now_novella_clinical_984618

14 Apr 2008:

Chiltern opens office in Russia

UK-based contract research organisation (CRO) Chiltern has stepped up its presence in Russia and the wider Central and Eastern European (CEE) market by opening an office in St. Petersburg. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/chiltern_opens_office_in_russia_987293

13 Jul 2009:

ICON acquires biomarker specialist Veeda Laboratories

ICON, the international contract research organisation (CRO) based in Ireland, has beefed up its bioanalytical and immunoassay capabilities by acquiring Veeda Laboratories Ltd for an undisclosed sum. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/icon_acquires_biomarker_specialist_veeda_laboratories_984499

20 Jun 2013:

New US facility for TKL Research

US-based clinical research organisation (CRO) TKL Research is adding to its cluster of research clinics in northern New Jersey with the construction of a new facility in Fair Lawn, which will include a 30-bed unit for Phase I trials. - News -

by Peter Mansell

https://www.pharmatimes.com/news/new_us_facility_for_tkl_research_1005236

23 Feb 2009:

Frontage Laboratories digs deeper in China

Frontage Laboratories, a US-based provider of bio-analytical, preclinical, clinical and drug development services, is deepening its involvement in China by expanding an existing research and development agreement with Beijing Second Pharmaceuticals,

by Peter Mansell

https://www.pharmatimes.com/news/frontage_laboratories_digs_deeper_in_china_985425

3 Oct 2013:

EMA closes consultation on data transparency

The European Medicines Agency (EMA) has now closed its three-month public consultation on a draft policy for access to, and publication of, clinical-trial data. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/ema_closes_consultation_on_data_transparency_1005790

13 Mar 2012:

Spaulding Clinical joins clinicalRSVP registry network

Spaulding Clinical Research, the US-based provider of clinical pharmacology and cardiac core-laboratory services, is joining the network of clinical trial sites that participate in clinicalRSVP’s Research Subject Verification Program. - News -

by Peter Mansell

https://www.pharmatimes.com/news/spaulding_clinical_joins_clinicalrsvp_registry_network_975587